Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

NHC

NHC President and COO Retires

National Healthcare Corporation (NYSE American: NHC) has announced the retirement of R. Michael Ussery, the company's President and Chief Operating Officer, effective December 31, 2025. Ussery has had a distinguished 45-year career with NHC, having joined the company in 1980 and holding various operational and leadership roles before being appointed as COO in 2009 and President in 2017.

During Ussery's tenure as President and COO, NHC has seen significant periods of change and growth. The company operates 80 skilled nursing facilities with 10,349 beds, 26 assisted living communities with 1,413 units, nine independent living communities with 777 units, three behavioral health hospitals, 34 homecare agencies, and 32 hospice agencies. Additionally, NHC provides Alzheimer's and memory care units, pharmacy services, rehabilitation services, and management and accounting services to third-party post-acute operators.

Under Ussery's leadership, NHC has continued its mission of providing exceptional care, with a focus on high-quality patient care. The company has also seen growth in its services, reflecting the changing needs of the healthcare industry. Ussery's retirement marks the end of an era at NHC, and his contributions to the company's success and growth over the decades are notable.

As NHC bids farewell to Ussery, the company expresses confidence in the future and is committed to continuing its mission of providing exceptional care. As a result of these announcements, the company's shares have moved 3.38% on the market, and are now trading at a price of $126.41. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS